Terazocin 2mg and 5mg per tablet
AMDIPHARM (U.K.)
Use in benign Prostatic Hyperplasia:
Studies suggest that alpha-1-adrenoreceptor antagonism is useful in improving the urodynamics in patients with chronic obstruction such as in benign prostatic hyperplasia (BPH).
Use in hypertension:
Although the exact mechanism of the hypotensive action is not established, the relaxation of peripheral blood vessels appears to be produced mainly by competitive antagonism of post-synaptic alpha-1-adrenoceptor. Terazosin usually produces an initial gradual decrease in blood pressure followed by a sustained anti hypertensive action.
-
- Indications
Terazosin tablets are indicated for:
• the treatment of mild to moderate hypertension
• symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia (BPH).
Posology:
For oral use.
For the different dosage regimens suitable strengths are available.
The dose of terazosin should be adjusted according to the patient’s response.